S&P 500
Nasdaq
Dow Jones
NVDA
AAPL
TSLA
MSFT
BTC-USD
15-min delayed
Live
Home Market News Price Targets Penny Stocks Crypto Economy Commodities Education
Stocks About Contact

PTC Therapeutics, Inc.

PTCT XNAS
$73.69 +9.20 (+14.27%) ▲ 15-min delayed
Open
$74.07
High
$79.91
Low
$69.42
Volume
5.84M
Market Cap
$6.11B

About PTC Therapeutics, Inc.

PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The company views its operations and manages its business in one operating segment: life science, which is focused on the discovery, development and commercialization of the company's clinically differentiated medicines that provide benefits to patients with rare disorders.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 991 Website →

Key Financials

Period Revenue Net Income EPS
Q1 2026 $272.55M $-2,809,000 $-0.03
FY 2025 $1.73B $682.64M $8.58
Q3 2025 $211.01M $15.90M $0.20
Q2 2025 $178.88M $-64,849,000 $-0.83

Earnings & Analyst Ratings

Next Earnings: Wed, Aug 5, 2026
Calendar →

Related Market News

No specific coverage for PTCT yet. Check out our latest market news or earnings calendar.

Get PTCT Alerts

Stay ahead with breaking news, price alerts, and expert analysis on PTC Therapeutics, Inc..

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.